News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
IASO Bio Gains U.S. FDA Approval for Investigational New Drug Application of Equecabtagene Autoleucel for Two New Autoimmune Disease Indications
Monday, August 12, 2024IASO Biotherapeutics a biopharmaceutical company dedicated to discovering developing manufacturing and commercializing innovative cell therapy and antibody products today announced that the investigational new drug IND application
Recursion and Exscientia Enter Agreement to Establish a Global Leader in Technology-Driven Drug Discovery with Comprehensive End-to-End Capabilities
Friday, August 09, 2024Recursion and Exscientia plc announced the companies have entered into a definitive agreement combining Recursion a leading clinical stage technologyenabled biotech company decoding biology to industrialize drug discovery with Exscientia a technology...
Pharmacosmos Group to Acquire G1 Therapeutics
Thursday, August 08, 2024G Therapeutics Inc a commercialstage oncology company focused on delivering nextgeneration therapies that improve the lives of those affected by cancer and Pharmacosmos AS a leader in the development of innovative treatments for patients suffering fr...
Bavarian Nordic Secures $156.8 Million from U.S. Government for Expanded Smallpox/Mpox Vaccine Production
Thursday, August 08, 2024Bavarian Nordic AS announced it has received a new order worth USD million from the Biomedical Advanced Research and Development Authority BARDA part of the Administration for Strategic Preparedness and Response within the US
OKYO Pharma Receives European Patent for OK-101 Chemerin Analogs and Their Method of Use
Wednesday, August 07, 2024OKYO Pharma Limited a clinicalstage biopharmaceutical company developing innovative ocular therapies for the treatment of inflammatory dry eye disease DED a multibilliondollar market and anterior ocular segment diseases including neuropathic corneal...
Gelteq Enhances Partnership with Monash Innovation Labs
Wednesday, August 07, 2024Gelteq Limited a global biotechnology firm specializing in ingestible gel technology is expanding its partnership with Monash University ranked in the world for pharmaceutical science The Company is setting up a new fulltime research and development...
Mallinckrodt Agrees to Sell Therakos® Business to CVC for $925 Million
Tuesday, August 06, 2024Mallinckrodt plc a global specialty pharmaceutical company and CVC Capital Partners CVC a leading investment firm have announced a definitive agreement in which CVC Capital Partners Fund IX will acquire Mallinckrodts Therakos business for million
Salubris Biotherapeutics Granted EMA Approval to Begin Phase 1 Trial of JK06, a 5T4-Targeted ADC for Solid Tumors
Monday, August 05, 2024Salubris Biotherapeutics Inc a biotech company in the clinicalstage focusing on innovative biologic therapies has received approval from the European Medicines Agency to start a Phase clinical trial
CStone Receives European Commission Approval for Sugemalimab (Cejemly®) as a First-Line Treatment for Non-Small Cell Lung Cancer
Saturday, August 03, 2024CStone Pharmaceuticals an innovative biopharmaceutical firm specializing in cancer therapies has announced that the European Commission has approved sugemalimab for use
Merck Finalizes Mirus Bio Acquisition, Enhancing Its Viral Vector Bioprocessing Offerings
Friday, August 02, 2024Merck a prominent science and technology firm has finalized its acquisition of Mirus Bio for approximately million million This transaction which concluded after securing regulatory approvals
